Search This Blog

Tuesday, December 11, 2018

Clovis Oncology (CLVS) Named Best 2019 Idea at Gabelli on Takeover Potential


Gabelli analyst Jing He named Clovis Oncology (NASDAQ: CLVS) a Best Idea for 2019, calling it a potential takeover target

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.